Matches in Wikidata for { <http://www.wikidata.org/entity/Q90361718> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q90361718 description "article scientifique publié en 2019" @default.
- Q90361718 description "artículu científicu espublizáu en setiembre de 2019" @default.
- Q90361718 description "scientific article published on 29 September 2019" @default.
- Q90361718 description "wetenschappelijk artikel" @default.
- Q90361718 description "наукова стаття, опублікована 29 вересня 2019" @default.
- Q90361718 name "Cabozantinib use in metastatic renal cell carcinoma patients in clinical practice: Evaluation of dosing patterns, tolerability, and outcomes compared to clinical trials" @default.
- Q90361718 name "Cabozantinib use in metastatic renal cell carcinoma patients in clinical practice: Evaluation of dosing patterns, tolerability, and outcomes compared to clinical trials" @default.
- Q90361718 type Item @default.
- Q90361718 label "Cabozantinib use in metastatic renal cell carcinoma patients in clinical practice: Evaluation of dosing patterns, tolerability, and outcomes compared to clinical trials" @default.
- Q90361718 label "Cabozantinib use in metastatic renal cell carcinoma patients in clinical practice: Evaluation of dosing patterns, tolerability, and outcomes compared to clinical trials" @default.
- Q90361718 prefLabel "Cabozantinib use in metastatic renal cell carcinoma patients in clinical practice: Evaluation of dosing patterns, tolerability, and outcomes compared to clinical trials" @default.
- Q90361718 prefLabel "Cabozantinib use in metastatic renal cell carcinoma patients in clinical practice: Evaluation of dosing patterns, tolerability, and outcomes compared to clinical trials" @default.
- Q90361718 P1433 Q90361718-1CC2D8EC-FB86-43D4-8FC9-FE7648FBEA6B @default.
- Q90361718 P1476 Q90361718-8BD90363-5CD0-480A-A8F8-FDFD934001BD @default.
- Q90361718 P2093 Q90361718-5C414FE9-4692-412B-818F-B1B83321CB83 @default.
- Q90361718 P2093 Q90361718-89284C9F-C2F7-44DE-9A7A-7198D24F7D3F @default.
- Q90361718 P2093 Q90361718-9AA39F67-65B5-4FC5-8E3D-50C500AE02E0 @default.
- Q90361718 P304 Q90361718-D9A96B86-4818-487D-B22B-C398EA4F8EAE @default.
- Q90361718 P31 Q90361718-A8061227-C91C-4D8E-BDA0-0FF1412D366B @default.
- Q90361718 P356 Q90361718-471FBEDF-0881-4DDC-98DA-993C4CEA945D @default.
- Q90361718 P50 Q90361718-3F458175-DB16-4D1E-8AE8-B1CF29D15285 @default.
- Q90361718 P50 Q90361718-B5E136E0-CC06-4E17-9C09-C3D842F55EE9 @default.
- Q90361718 P577 Q90361718-7B24BA1E-CC28-421A-B02C-52337B5D4A7C @default.
- Q90361718 P698 Q90361718-C42C5485-B84E-4980-A887-4BBD90024B90 @default.
- Q90361718 P921 Q90361718-70E34600-67CC-4E6C-83C9-372199C67CC4 @default.
- Q90361718 P921 Q90361718-F174466D-2577-4232-B341-6C423E898CE7 @default.
- Q90361718 P356 1078155219875509 @default.
- Q90361718 P698 31566113 @default.
- Q90361718 P1433 Q6295681 @default.
- Q90361718 P1476 "Cabozantinib use in metastatic renal cell carcinoma patients in clinical practice: Evaluation of dosing patterns, tolerability, and outcomes compared to clinical trials" @default.
- Q90361718 P2093 "Amy M Sion" @default.
- Q90361718 P2093 "Jennifer Mikoll" @default.
- Q90361718 P2093 "Theodore S Gourdin" @default.
- Q90361718 P304 "1078155219875509" @default.
- Q90361718 P31 Q13442814 @default.
- Q90361718 P356 "10.1177/1078155219875509" @default.
- Q90361718 P50 Q57570830 @default.
- Q90361718 P50 Q90361714 @default.
- Q90361718 P577 "2019-09-29T00:00:00Z" @default.
- Q90361718 P698 "31566113" @default.
- Q90361718 P921 Q1164529 @default.
- Q90361718 P921 Q19000948 @default.